文献速递心力衰竭与心肌病

加拿大与美国心力衰竭住院患者再入院率及住院时长趋势

Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United States.
PubMed 文献 · JAMA Cardiol · 2019-01-01

该队列研究分析2005年4月至2015年12月加拿大与美国心力衰竭住院患者,发现两国30天再入院率均下降,但住院时长在加拿大仅轻微下降、美国保持稳定。分段回归分析显示,美国医院再入院减少计划实施前后再入院率趋势无显著差异,提示该计划未明显影响心衰再入院或住院时长。

要点

  • 加拿大与美国心衰患者30天再入院率在2005-2015年均下降,全因和心衰特异性再入院率降幅相似。
  • 美国住院时长稳定在约4.9天,加拿大仅从7.5天轻微降至7.3天。
  • 美国医院再入院减少计划实施前后,再入院率趋势斜率无显著变化。

核心结论

  • 加拿大与美国心衰患者30天全因再入院率在过去十年均呈相似下降趋势。
  • 美国医院再入院减少计划似乎与心衰再入院率下降趋势或住院时长无关。

研究设计与样本

  • 队列研究纳入2005年4月1日至2015年12月31日加拿大与美国医院以心衰为主要诊断的住院患者。
  • 采用分段回归模型检验医院再入院减少计划实施后的变化,并用多变量logistic回归分析住院时长与再入院的关联。

主要发现

  • 加拿大平均住院时长从7.5(5.7)天降至7.3(5.6)天(P < .001),美国从4.9(3.7)天至4.9(3.5)天保持稳定。
  • 美国全因30天再入院率从21.2%降至18.5%,心衰特异性再入院率从7.6%降至5.7%(均P < .001)。
  • 住院时长与30天再入院呈弱正相关:加拿大OR 1.01(95%CI 1.01-1.01),美国OR 1.01(95%CI 1.01-1.01)。

临床怎么用

  • 心衰再入院率下降是两国共有的长期趋势,临床质量改进应关注再入院之外的综合管理。
  • 住院时长与再入院仅呈弱相关,缩短住院时长可能不是降低再入院的有效靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Over the past decade, reducing 30-day readmission rates has been emphasized in the United States (including via the implementation of the Hospital Readmissions Reduction Program) but not Canada. OBJECTIVE: To examine changes that occurred from April 1, 2005, to December 31, 2015, in the United States and Canada for hospitalization length of stay and 30-day readmission rates of patients with heart failure. DESIGN, SETTING, AND PARTICIPANTS: This cohort study included patients admitted with a primary diagnosis of heart failure to Canadian and US hospitals between April 1, 2005, and December 31, 2015, using International Classification of Diseases, Ninth Revision code 428.xx and Tenth Revision code I50. The study examined secular trends in length of stay and readmissions in both countries and tested for changes after implementation of the Hospital Readmissions Reduction Program using segmented regression models and the association between length of stay and readmissions using patient-level and hospital-level multivariable logistic regression models. Data analysis was completed from February 2018 to August 2018. MAIN OUTCOMES AND MEASURES: Thirty-day readmissions. RESULTS: Between 2005 and 2015, mean length of stay declined marginally in Canadian hospitals (from a mean [SD] of 7.5 [5.7] to 7.3 [5.6] days; P < .001) but remained stable in US hospitals (mean [SD], 4.9 [3.7] days to 4.9 [3.5] days). Thirty-day readmission rates declined similarly in Canada (from 4088 of 20 758 patients [19.7%] to 3823 of 21 733 patients [17.6%] for all-cause readmissions; P < .001; and from 1743 of 20 758 patients [8.4%] to 1490 of 21 733 patients [6.9%] for heart failure-specific readmissions; P < .001) and the United States (from 21.2% to 18.5% for all-cause readmissions; from 7.6% to 5.7% for heart failure-specific readmissions; both P < .001). There were small but statistically significant positive correlations between length of stay and 30-day readmissions in both Canada (odds ratio, 1.01 [95% CI, 1.01-1.01]) and the United States (odds ratio, 1.01 [95% CI, 1.01-1.01]). Interrupted time-series analysis comparing readmission rates before and after the Hospital Readmissions Reduction Program implementation revealed no significant difference in either country for all-cause readmission rates before and after October 2012. There was also no change in the slope of the temporal trends; in Canada, all-cause readmissions were decreasing 1.1% per year before implementation and 1.3% after implementation (P = .84 for slope change) compared with 1.6% per year in the United States before implementation and 1.8% per year after October 2012 (P = .60 for slope change). CONCLUSIONS AND RELEVANCE: Both Canada and the United States exhibited similar temporal declines in 30-day all-cause readmissions over the past decade. These findings suggest that the Hospital Readmissions Reduction Program did not appear to be associated with this secular trend or length of stay for heart failure in the United States.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Samsky MD, Ambrosy AP, Youngson E, et al. Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United States. JAMA Cardiol. 2019. PMID: 30969316. doi:10.1001/jamacardio.2019.0766

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。